Pharma

Caplin Point Laboratories Ltd

CAPLIPOINT · NSE · INE475E01026
——consolidatedstandalone
Sentiment73 · Greed
Extreme FearFearNeutralGreedExtreme Greed
Market Cap—
P/E30.2
P/B5.7
EPS₹87.28
Div Yield0.4%
ROE21.7%
ROCE22.0%
ROE21.7%
1Y Return+45.49%
Avg. Volume0.1M

Price Chart

2,8472,5122,1761,8401,50510.0L19.9LOct 2025Nov 2025Dec 2025Jan 2026Mar 2026Apr 2026May 2026Jul 2026Aug 2026

About

Caplin Point Laboratories Ltd is a Pharma company listed on NSE.

Pharma

Technicals

Free account

Technicals

Create a free account to view momentum, moving averages, and delivery signals.

Register free

Quant

Premium

Quant metrics

Upgrade to view volatility, drawdown, factor, and risk metrics.

Upgrade

Key Ratios

Market Cap—
Current Price—
52W High / Low—
Stock P/E30.2
Price to Book5.7
EPS (TTM)₹87.28
Dividend Yield0.4%
ROE21.7%
1Y Return+45.49%
Day Change—

Profit & Loss

ConsolidatedStandalone
Profit and loss statement
PeriodTTMFY26FY25FY24FY23FY22FY21FY20FY19FY18FY17FY16
Sales₹2,287 Cr₹2,187 Cr₹1,937 Cr
Expenses₹1,491 Cr₹1,422 Cr₹1,287 Cr
Operating Profit₹797 Cr₹765 Cr₹651 Cr
OPM %35.0%35.0%34.0%
Other Income₹126 Cr₹111 Cr₹92 Cr
Depreciation₹78 Cr₹73 Cr₹66 Cr
Interest₹1 Cr₹1 Cr₹1 Cr
Profit Before Tax₹844 Cr₹803 Cr₹677 Cr
Tax₹166 Cr₹153 Cr₹136 Cr
Net Profit₹678 Cr₹650 Cr₹541 Cr
EPS (₹)87.584.470.6
Dividend Payout %—9%8%
Financial history locked

Register free to see 9 more years.

Register free

Quarterly Results

Quarterly results
QuarterJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023Sep 2023Jun 2023
Sales₹610 Cr₹600 Cr₹543 Cr₹534 Cr
Expenses₹397 Cr₹396 Cr₹353 Cr₹345 Cr
Operating Profit₹213 Cr₹204 Cr₹190 Cr₹189 Cr
OPM %35.0%34.0%35.0%35.0%
Depreciation₹22 Cr₹19 Cr₹19 Cr₹18 Cr
Interest₹0 Cr₹0 Cr₹0 Cr₹0 Cr
Net Profit₹179 Cr₹173 Cr₹166 Cr₹160 Cr
EPS (₹)23.322.421.620.3
Quarterly history locked

Register free to see 9 more quarters.

Register free

Balance Sheet

Balance sheet
PeriodFY26FY25FY24FY23FY22FY21FY20FY19FY18FY17FY16
Liabilities
Equity Capital₹15 Cr₹15 Cr₹15 Cr
Reserves₹3,355 Cr₹2,619 Cr₹2,084 Cr
Borrowings₹221 Cr₹222 Cr₹219 Cr
Other Liabilities₹447 Cr₹352 Cr₹380 Cr
Total Liabilities₹4,038 Cr₹3,208 Cr₹2,698 Cr
Assets
Fixed Assets₹580 Cr₹546 Cr₹453 Cr
Investments₹859 Cr₹590 Cr₹376 Cr
Receivables———
Inventory———
Cash & Equivalents———
Other Assets₹2,365 Cr₹1,928 Cr₹1,753 Cr
Total Assets₹4,038 Cr₹3,208 Cr₹2,698 Cr
Balance sheet history locked

Register free to see 9 more years.

Register free

Cash Flow

Cash flow statement
PeriodOperatingInvestingFinancingNet Cash Flow
FY26₹523 Cr₹-582 Cr₹-46 Cr₹-105 Cr
FY25₹432 Cr₹-333 Cr₹-38 Cr₹61 Cr
FY24₹318 Cr₹-319 Cr₹-38 Cr₹-39 Cr
FY23
FY22
FY21
FY20
FY19
FY18
FY17
FY16
Cash flow history locked

Register free to see 9 more years.

Register free

Peer Comparison

Peer comparison
CompanyM.CapP/EROE1Y Return
3B BlackBio Dx Ltd₹1,210 Cr21.4+20.2%+17.9%
Aarey Drugs & Pharmaceuticals Ltd₹353 Cr75.3+2.75%+59.84%
Aarti Drugs Ltd₹3,429 Cr18.0+13.37%+11.57%
Aarti Pharmalabs Ltd₹7,495 Cr35.2+8.51%+14.26%
Abbott India Ltd——+34.46%-7.16%

Mutual Fund Holdings

Free account

Mutual fund holdings

Create a free account to see institutional ownership snapshots.

Register free

Bulk & Block Deals

Free account

Bulk & block deals

Create a free account to view recent institutional deal activity.

Register free

Analyst Estimates

Free account

Analyst estimates

Create a free account to view analyst estimate summaries.

Register free

Latest News

2026-09-25Clarification With Respect To Volume MovementBSE Filing2026-08-14Caplin Point Laboratories Ltd (BOM:524742) (Q1 2027) Earnings Call Highlights: US Injectable ...GuruFocus.com

Documents & Filings

rupiya.io is for research and education only. Metrics shown are not investment advice. Validate with SEBI-regulated disclosures before acting.